The proportion of women with overweight or obesity has increased steadily over the past two decades, representing a concerning trend for pregnancy outcomes. Excess weight represents an important risk factor for pregnancy complications, including preeclampsia, eclampsia, gestational diabetes mellitus, gestational hypertension, and disorders of placental development and implantation. Overweight and obesity are closely associated with oxidative stress, insulin resistance, and altered nitric oxide bioavailability. The aim of this study. To investigate the principal metabolic and endothelial disturbances and establish their association with adverse pregnancy outcomes in women with overweight. Materials and methods. Sixty-eight pregnant women with overweight and 49 pregnant women with normal BMI were included in the study. Endothelial dysfunction was assessed by measuring serum levels of endothelin-1 and nitric oxide (NO) using enzyme immunoassay. Dynamic monitoring of endothelial dysfunction markers was performed throughout pregnancy in women with elevated and normal baseline BMI. Informed consent in written form was secured from all study participants prior to enrollment. Data were analyzed using Microsoft Excel and Statistica 12.0 software (StatSoft Inc., USA). Pearson's correlation coefficient was used for correlation analysis. Normality of distribution was assessed using the D'Agostino and Shapiro–Wilk tests, with normal distribution confirmed in most groups (p > 0.05). Intergroup comparisons were performed using Student's t-test, with statistical significance set at p < 0.05. The study protocol was approved by the Ethics Committee of Ivano-Frankivsk National Medical University (Protocol No. 118/20, dated December 15, 2020) and conducted at the Municipal Clinical Perinatal Center of the Ivano-Frankivsk City Council, Ivano-Frankivsk, as part of the comprehensive research project "Development of diagnostic strategies and pathogenetic justification of effective methods for preserving and restoring reproductive potential and improving quality of life parameters in women with obstetric and gynecological pathologies" (No. 0121U109269). Results. During the first trimester, pregnant women with overweight demonstrated vasoconstrictor ET-1 levels 2.3-fold higher and NO metabolite concentrations 1.3-fold lower than those observed in the normal-BMI group (p < 0.05 for both). Longitudinal assessment revealed a significant decline in NO metabolite concentrations by late pregnancy relative to the first trimester, with reductions of 1.2-fold, 1.1-fold, and 1.2-fold in pregnancies resulting in recommended, insufficient, and excessive fetal weight, respectively (all p < 0.05). Within the subgroup characterized by excessive gestational weight gain, NO levels were further reduced by 1.2-fold compared with the normal-weight-gain subgroup (p < 0.05). Among women who subsequently developed gestational hypertension or preeclampsia and who had overweight during the pre-conception period, vasoconstrictor ET-1 production was increased 1.6-fold and 1.7-fold, respectively, relative to women with normal BMI (both p < 0.05), with NO levels correspondingly lower in both outcome groups among women with overweight compared with their normal-BMI counterparts (p < 0.05). During the first trimester, women with overweight who later developed gestational hypertension exhibited vasoconstrictor ET-1 levels 1.9-fold higher and NO metabolite concentrations 1.2-fold lower than pregnant women with normal BMI (both p < 0.05). At 11–13 weeks' gestation, a comparable pattern was observed in women with overweight who subsequently developed gestational diabetes, with vasoconstrictor ET-1 concentrations 1.7-fold higher and NO metabolite levels 1.3-fold lower than in women with normal BMI (both p < 0.05). Conclusions. Overweight in pregnancy is strongly associated with elevated markers of endothelial dysfunction, characterized by increased pro-oxidant system activity and reduced antioxidant system activity. Endothelial dysfunction marker levels in early pregnancy additionally demonstrate a strong correlation with the risk of subsequent gestational diabetes and hypertensive disorders in late pregnancy among women with overweight.